Natalie Grover
Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
Just-approved ALS drug edaravone shown to significantly slow functional decline
The Food and Drug Administration on Friday [May 5, 2017] approved Mitsubishi Tanabe Pharma Corp's treatment for fatal neurological disorder ...
